American Hospital Association

CMS proposes new drug pricing model to expand GLP-1 access to those with Medicare Part D and Medicaid

The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...
Fierce Healthcare

CMMI releases three new models aimed at lower generic, novel drug costs

The Biden administration rolled out three new payment models intended to lower drug costs, including new Medicare coverage options for drugs cleared under accelerated approval. The release of the ...

President Trump calls new drug pricing deal 'the biggest thing ever'

President Trump has announced a new agreement with nine major drug companies to lower drug prices in the U.S., promising ...
The American Journal of Managed Care

Medicare $2 Drug List Model Could Have Reduced 2021 Out-of-Pocket Generic Costs

Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...
The American Journal of Managed Care

CMS Releases Preliminary Drug List for Medicare $2 Drug List Model

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...